TruCal® (Milk Mineral Complex for Bone Health — Glanbia Nutritionals)

Evidence Level
Limited
2 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

TruCal® is Glanbia Nutritionals' branded milk mineral complex — a calcium source extracted from fresh cow's milk that delivers calcium alongside the full natural mineral matrix found in milk and bone: phosphorus, magnesium, potassium, zinc, copper, and iron. Composition: 25% calcium, 12% phosphorus, 0.37% magnesium, plus trace minerals — with a calcium:phosphorus ratio of ~1.8:1 matching natural bone composition. Distinguished from calcium carbonate and other isolated calcium salts by providing the synergistic mineral matrix rather than calcium alone. The published human evidence used a generic calcium-fortified milk matrix (not branded TruCal) and measured bone-turnover markers: overnight or 24-week ingestion lowered the resorption marker CTX in osteopenic postmenopausal women. In the one 24-week trial there was no change in bone mineral density or trabecular bone score. The claim that TruCal lowers bone resorption more than calcium carbonate comes from an unpublished Glanbia dossier, not a peer-reviewed trial, and the pre-exercise resorption result comes from a Glanbia press release. No fracture or bone-density benefit specific to TruCal has been shown.

Studied Dose 700-1,000 mg/day (delivering ~175-250 mg elemental calcium); split doses ≤500 mg elemental calcium.
Active Compound Milk mineral complex (25% calcium, 12% phosphorus, 0.37% magnesium, plus potassium, zinc, copper, iron; Ca:P ~1.8:1).

Benefits

Reduced bone-turnover markers (generic milk matrix)

In published trials a generic calcium-fortified milk matrix (not branded TruCal) lowered the bone-resorption marker CTX by about 23 to 32 percent versus control in osteopenic postmenopausal women. These are short-term turnover markers, not bone density or fracture outcomes, and the 24-week trial found no change in bone mineral density. The claim that TruCal beats calcium carbonate comes from an unpublished company dossier, and the pre-exercise resorption result from a Glanbia press release, neither of them peer-reviewed.

Complete bone mineral matrix delivery

Bone is built from multiple minerals — calcium alone isn't sufficient. TruCal delivers calcium plus phosphorus, magnesium, potassium, zinc, copper, and iron in ratios matching natural bone composition. Reduces concerns about calcium-only supplementation imbalances (e.g., high-dose isolated calcium may displace magnesium absorption).

Food-form (dairy-derived) calcium

Calcium from food sources (especially dairy) has different metabolic behavior than isolated calcium salts — generally better tolerated and possibly less associated with cardiovascular calcification concerns that have been raised with high-dose isolated calcium supplements. The natural matrix may support physiological calcium handling.

Clean flavor profile and formulation flexibility

Unlike calcium carbonate (chalky taste), calcium citrate (acidic, sour), or calcium gluconate (sweet), TruCal has a bland flavor profile suitable for ready-to-mix beverages, yogurt, bars, processed cheese, bakery, cereals, snacks, capsules, and tablets without dominating finished product taste.

Good solubility at acidic pH

Solubility at acidic pH supports absorption in the acidic stomach environment — addressing one of the limitations of calcium carbonate, which requires adequate stomach acid for dissolution and is poorly absorbed in those with low gastric acid (elderly, PPI users). TruCal's milk-derived form maintains consistent solubility across pH ranges.

Sports nutrition application (exercise-induced bone stress)

A Glanbia press release describes a 10-subject crossover study in which 1,000 mg TruCal before moderate exercise lowered exercise-associated bone-resorption markers. This study has not been published in a peer-reviewed journal, so the pre-exercise application rests on unpublished manufacturer data rather than independent trial evidence.

Mechanism of action

1

Multi-mineral synergy for bone formation

Bone matrix requires calcium (hydroxyapatite), phosphorus (the other half of hydroxyapatite), magnesium (cofactor for bone matrix protein synthesis), potassium (acid-base balance for bone preservation), and trace minerals (zinc, copper for collagen cross-linking). Providing these together in physiological ratios supports optimal osteoblast function.

2

Reduced osteoclast activity

Published trials of a generic milk-based calcium matrix (not branded TruCal) documented reductions in bone-resorption markers such as CTX, consistent with suppressed osteoclast (bone-resorbing cell) activity. The claim that this exceeds calcium carbonate at equivalent doses comes from an unpublished company dossier, not a peer-reviewed comparison.

3

Casein phosphopeptide carriers (milk-derived)

Milk-derived calcium sources retain trace amounts of casein phosphopeptides (CPP) — small peptides that improve calcium absorption by maintaining calcium solubility in the alkaline small intestine. This may partly explain the bioavailability advantage of milk-derived calcium vs inorganic calcium salts.

4

Calcium-phosphorus ratio optimization

The 1.8:1 calcium-to-phosphorus ratio in TruCal matches natural bone composition. Calcium-only supplements skew this ratio dramatically; modern diets are often relatively phosphorus-excessive (processed foods). TruCal's balanced ratio supports homeostatic mineral handling.

Clinical trials

1
TruCal for Exercise-Associated Bone Resorption (UNPUBLISHED Glanbia press release, not peer-reviewed)

Randomized double-blind placebo-controlled crossover trial at University of Limerick (Ireland) Human Science Research Unit.

10 subjects

Randomized double-blind placebo-controlled crossover trial at University of Limerick (Ireland) Human Science Research Unit. 10 subjects rotated through four conditions: TruCal 1,000 mg or placebo, with or without moderate exercise. Outcome: prior ingestion of TruCal before exercise significantly reduced exercise-associated bone resorption markers vs placebo. These results come from an unpublished Glanbia press release and have not appeared in a peer-reviewed journal.

2
TruCal vs Calcium Carbonate (UNPUBLISHED Glanbia dossier, not a peer-reviewed trial)

Human clinical study (referenced in Glanbia clinical dossier and report): TruCal significantly lowered markers of bone resorption and bone turnover compared to calcium carbonate at equivalent calcium content over a 6-week supplementation period.

Not published; no trial publication exists. Claim sourced to an internal Glanbia dossier.

Human clinical study (referenced in Glanbia clinical dossier and report): TruCal significantly lowered markers of bone resorption and bone turnover compared to calcium carbonate at equivalent calcium content over a 6-week supplementation period. Supports the differentiated mechanism vs standard calcium supplements — a meaningful differentiator among calcium ingredients.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated; better GI tolerability than calcium carbonate in many users.
Milk-derived — not suitable for individuals with cow's milk protein allergy or strict vegan diets. Lactose content may be low but not zero (specification depends on grade).
Possible constipation at very high doses (a known calcium supplementation issue).
Theoretical cardiovascular calcification concern with very-high-dose isolated calcium supplementation; the milk-matrix form may reduce this risk vs isolated calcium salts but long-term comparative trials are limited.
Kidney stone risk in susceptible individuals at high doses — split doses with meals.

Important Drug interactions

Tetracycline and fluoroquinolone antibiotics — calcium binds these antibiotics and reduces absorption; separate dosing by 2-4 hours.
Thyroid medications (levothyroxine) — calcium impairs levothyroxine absorption; separate dosing by 4 hours.
Bisphosphonates — calcium impairs absorption; separate dosing by ≥30 minutes (usually take bisphosphonate first thing AM, calcium later).
Iron supplements — competitive absorption; separate doses by 2 hours.
Proton pump inhibitors — chronic acid suppression impairs calcium carbonate absorption but has less effect on TruCal due to better pH-independent solubility.
Pregnancy and lactation — milk-derived calcium generally well-tolerated; calcium RDA in pregnancy is 1,000-1,300 mg/day depending on age.

Frequently asked questions about TruCal® (Milk Mineral Complex for Bone Health — Glanbia Nutritionals)

What is TruCal?

TruCal® is Glanbia Nutritionals' branded milk mineral complex — a calcium source extracted from fresh cow's milk that delivers calcium alongside the full natural mineral matrix found in milk and bone: phosphorus, magnesium, potassium, zinc, copper, and iron. Composition: 25% calcium, 12% phosphorus, 0.

What is TruCal used for?

TruCal is researched primarily for Bone Health. In published trials a generic calcium-fortified milk matrix (not branded TruCal) lowered the bone-resorption marker CTX by about 23 to 32 percent versus control in osteopenic postmenopausal women.

What is the recommended dosage of TruCal?

The clinically studied dose is 700-1,000 mg/day (delivering ~175-250 mg elemental calcium); split doses ≤500 mg elemental calcium. Always follow the product label and check with a healthcare provider for personal advice.

Is TruCal safe, and does it have side effects?

For most healthy adults, TruCal is well tolerated at studied doses. Reported effects can include: Generally well-tolerated; better GI tolerability than calcium carbonate in many users. Milk-derived — not suitable for individuals with cow's milk protein allergy or strict vegan diets. Lactose content may be low but not zero (specification depends on grade). It may also interact with some medications. TruCal is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does TruCal interact with any medications?

Possible interactions include: Tetracycline and fluoroquinolone antibiotics — calcium binds these antibiotics and reduces absorption; separate dosing by 2-4 hours. Thyroid medications (levothyroxine) — calcium impairs levothyroxine absorption; separate dosing by 4 hours. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for TruCal?

NutraSmarts rates the evidence for TruCal as Limited (2 out of 5). It is backed by 2 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Hettiarachchi M, Cooke R, Norton C, Jakeman P. Temporal Change in Biomarkers of Bone Turnover Following Late Evening Ingestion of a Calcium-Fortified, Milk-Based Protein Matrix in Postmenopausal Women with Osteopenia. Nutrients. 2019;11(6):1413. doi: 10.3390/nu11061413.PubMedUsed to support: Small acute crossover RCT (industry-supplied dairy product) in which a calcium-fortified milk-based protein matrix (the same dairy calcium-phosphorus + milk-protein concept as TruCal, not branded TruCal) lowered the bone-resorption marker CTX by about 32% versus control overnight; the formation marker P1NP rose but not significantly. Supports the bone-turnover claim, but it is short-term, a surrogate marker, and a generic milk mineral matrix.
  2. Norton C, Hettiarachchi M, Cooke R, Kozior M, Kontro H, Daniel R, et al. Effect of 24-Week, Late-Evening Ingestion of a Calcium-Fortified, Milk-Based Protein Matrix on Biomarkers of Bone Metabolism and Site-Specific Bone Mineral Density in Postmenopausal Women with Osteopenia. Nutrients. 2022;14(17):3486. doi: 10.3390/nu14173486.PubMedUsed to support: 24-week RCT (industry-supplied dairy matrix, generic not branded TruCal) in osteopenic postmenopausal women: the milk-based calcium-phosphorus protein matrix significantly reduced serum CTX (~23%) and P1NP versus control, but produced NO significant change in bone mineral density or trabecular bone score - mixed result supporting bone-turnover but not BMD claims.
  3. Kruger MC, von Hurst PR, Booth CL, Kuhn-Sherlock B, Todd JM, Schollum LM. Postprandial metabolic responses of serum calcium, parathyroid hormone and C-telopeptide of type I collagen to three doses of calcium delivered in milk. J Nutr Sci. 2014;3:e6. doi: 10.1017/jns.2014.2.PubMedUsed to support: Small dose-ranging human trial (Kruger group, dairy-industry funded) showing calcium delivered in fortified milk dose-dependently raised serum calcium and suppressed PTH and the resorption marker CTX, with milk performing comparably to a calcium salt; supports acute calcium-absorption / bone-turnover-suppression claims for dairy calcium generally, not branded TruCal.